Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-08-20

Clinical Trial Update: Helicobacter Pylori and Iron Deficiency: Prevalence of Association and Effect of Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the association between Helicobacter pylori infection and iron-deficiency anemia and the impact of therapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Anemia, Iron-Deficiency, Helicobacter Pylori | Phase 4 | Status: WITHDRAWN